Definition, classification and diagnosis of pulmonary hypertension
European Respiratory Journal · 2024-10 · 64 (4) · 2401324
DOI: 10.1183/13993003.01324-2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 29.08.2024. Verfasst von Gabor Kovacs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria gabor.kovacs@uniklinikum.kages.at. Hauptthemen laut MEDLINE: Cardiac Catheterization, Hypertension, Pulmonary, Vascular Resistance. Die Arbeit wurde bisher 506-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a haemodynamic condition characterised by elevation of mean pulmonary arterial pressure (mPAP) >20 mmHg, assessed by right heart catheterisation. Pulmonary arterial wedge pressure (PAWP) and pulmonary vascular resistance (PVR) distinguish pre-capillary PH (PAWP ≤15 mmHg, PVR >2 Wood Units (WU)), isolated post-capillary PH (PAWP >15 mmHg, PVR ≤2 WU) and combined post- and pre-capillary PH (PAWP >15 mmHg, PVR >2 WU). Exercise PH is a haemodynamic condition describing a normal mPAP at rest with an abnormal increase of mPAP during exercise, defined as a mPAP/cardiac output slope >3 mmHg/L/min between rest and exercise. The core structure of the clinical classification of PH has been retained, including the five major groups. However, some changes are presented herewith, such as the re-introduction of “long-term responders to calcium channel blockers” as a subgroup of idiopathic pulmonary arterial hypertension, the addition of subgroups in group 2 PH and the differentiation of group 3 PH subgroups based on pulmonary diseases instead of functional abnormalities. Mitomycin-C and carfilzomib have been added to the list of drugs with “definite association” with PAH. For diagnosis of PH, we propose a stepwise approach with the main aim of discerning those patients who need to be referred to a PH centre and who should undergo invasive haemodynamic assessment. In case of high probability of severe pulmonary vascular disease, especially if there are signs of right heart failure, a fast-track referral to a PH centre is recommended at any point during the clinical workup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria gabor.kovacs@uniklinikum.kages.at.
- Ludwig Boltzmann Institute for Lung Vascular Research Graz, Graz, Austria.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Division of Medicine, University College London, London, UK.
- Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Guy's and St Thomas's NHS Foundation Trust, London, UK.
- National Heart and Lung Institute, Imperial College, London, UK.
ORCID-Profile: Christopher P Denton, David Montani
Zitieren
APA
Kovacs, G., Bartolome, S., Denton, C. P., Gatzoulis, M. A., Gu, S., Khanna, D., Badesch, D., & Montani, D. (2024). Definition, classification and diagnosis of pulmonary hypertension. European Respiratory Journal, 64(4), 2401324. https://doi.org/10.1183/13993003.01324-2024
Vancouver
Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, et al. Definition, classification and diagnosis of pulmonary hypertension. European Respiratory Journal. 2024;64(4):2401324. doi:10.1183/13993003.01324-2024
BibTeX
@article{Kovacs2024,
author = {Kovacs, Gabor and Bartolome, Sonja and Denton, Christopher P and Gatzoulis, Michael A and Gu, Sue and Khanna, Dinesh and Badesch, David and Montani, David},
title = {Definition, classification and diagnosis of pulmonary hypertension},
journal = {European Respiratory Journal},
year = {2024},
volume = {64},
number = {4},
pages = {2401324},
doi = {10.1183/13993003.01324-2024}
}
EUVIMED